How lab spaces for rent reduce the time between scientific discovery and commercialisation
In practice, most scientific breakthroughs rarely move directly from the laboratory bench to the marketplace. This isn’t because these discoveries are worthless or not worth investigating, but because commercialisation itself is a complex process that not all researchers are necessarily prepared for.
Bringing a biotech breakthrough to market requires more than just uncovering the mechanisms behind different phenomena. Further experimentation, validation, regulatory preparation, funding, and scaling must be done to prove commercial viability. Even after all that, further cases must still be made to attract partners, investors, customers, and other stakeholders.
As one might imagine, building out the infrastructure needed to move through these stages efficiently is an enormous task, particularly when you’re at the leading edge of science. Fortunately, this is now largely optional, thanks to the proliferation of shared laboratory facilities.
A lab space for rent can help research teams compress once-lengthy development timelines without compromising scientific rigour, simplifying future commercialisation. Once a novel idea, these facilities have already been validated in biotechnology hubs the world over, including in Singapore. Here’s why shared laboratories for rent are fast becoming critical for SG’s research-driven startups.
1) They remove the need for lengthy facility setups
Building a private laboratory from the ground up can be incredibly expensive and time-consuming. The world’s top biotechnology hubs also tend to have expensive real estate, which means setting up a worthwhile lab in those places will cost even more.
There are also challenges beyond simply securing premises. Startups that want a self-owned lab must also purchase equipment, install specialised systems, and ensure complete compliance with relevant safety standards. These costs will also increase as the company’s research needs become more specialised or its operations begin to scale.
Choosing shared laboratories allows startups to eliminate most of these early-stage complications. Researchers can access ready-to-use facilities almost immediately, allowing experiments and product development activities to begin sooner.
2) They provide access to advanced equipment
Shared facilities can provide budding life science startups with access to a wide range of sophisticated laboratory equipment that would otherwise be difficult or impractical to obtain. This can allow researchers to conduct high-quality experiments without waiting for the next funding rounds. As one might expect, faster access to critical instruments often translates directly into shorter development cycles.
3) They lower financial barriers to innovation
Commercialisation of scientific breakthroughs frequently requires multiple rounds of testing, refinement, and proof-of-concept work, particularly in tightly-regulated markets like Singapore. Excessive infrastructure expenses can divert resources away from these essential activities, which can mean a premature end for an otherwise promising venture.
Opting for shared facilities early on lets startups allocate more of their initial budgets towards research, talent acquisition, product development, and critical regulatory compliance work. This added bit of financial flexibility often enables smaller organisations to progress through typical commercialisation milestones more rapidly than would otherwise be possible.
4) They support faster validation and iteration
Scientific development at the very edge of biotechnology rarely follows a straight path. As a result, researchers must continually evaluate results and refine their approaches based on new findings. With ready access to laboratory facilities on demand, this becomes a lot simpler.
The right shared facilities allow teams to conduct experiments and make any improvements without the kinds of delays that would occur in self-owned labs. If a team needs an instrument for a one-off test, for instance, shared facilities may be able to immediately provide it at minimal cost. The ability to quickly validate and improve things can help researchers identify promising directions sooner while avoiding prolonged investment in approaches that ultimately prove ineffective.
5) They create better access to talent and expertise
Shared facilities are not just for startup researchers. In practice, they frequently attract communities of scientists, entrepreneurs, and industry experts from the entire breadth of the scientific community. You’ll also have top innovation teams from globally recognised multinationals working in the same building as government researchers, giving countless opportunities for building invaluable connections.
Indeed, this contact and support can help smaller organisations avoid common pitfalls, as they’ll be getting advice from talents who have seen it all. This can make it much easier for nascent biotechnology ventures to navigate the path to commercialisation with greater confidence.
6) They facilitate scalable growth
A major advantage of shared labs is that organisations can easily scale their resources according to their evolving needs. There is no need to build out more lab space or to purchase more equipment, as startups and innovation groups can simply rent as much or as little of these inputs as they need. This adaptability preserves research momentum and avoids the risks and lost opportunities from using facilities that don’t match current needs.
7) They align with Singapore’s innovation ecosystem
As a city-state with serious geographic and demographic limitations, Singapore has long prioritised the efficient use of limited land, talent, and resources. Shared laboratory models closely match this national approach by maximising the utilisation of specialised scientific infrastructure.
The country’s life sciences ecosystem is also supported by diverse public-private partnerships and programmes designed to put the best minds and funding opportunities in close proximity to each other. Sites like Biopolis and Geneo have already proven the value of this model in enabling biotechnology players of all sizes to efficiently reach breakthroughs and convert them into market-ready concepts and products.
Shared labs ease the journey from breakthrough to market
The many proven advantages of shared lab facilities make it difficult to justify self-owned facilities outside of a few edge cases. For startups eager to produce the next big patent or product, shared laboratories are fast becoming the sensible default.
This is largely a good thing. Singapore’s shared laboratories are breaking down long-existing barriers and helping underfunded researchers turn promising ideas into meaningful innovations. In a competitive and fast-moving sector such as life sciences, these seemingly small advantages can make a significant difference in how quickly lab breakthroughs reach the people and industries that need them the most.